Prevention of Peritransplantation Viridans Streptococcal Bacteremia with Early Vancomycin Administration: A Single‐Center Observational Cohort Study
Open Access
- 1 December 2004
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 39 (11) , 1625-1632
- https://doi.org/10.1086/425612
Abstract
Background. Viridans streptococcal bacteremia (VSB) after allogeneic hematopoietic stem cell transplantation (HSCT) is associated with substantial moKeywords
This publication has 21 references indexed in Scilit:
- Serious Complications of Bacteremia Caused by Viridans Streptococci in Neutropenic Patients with CancerClinical Infectious Diseases, 2000
- An Outbreak of Vancomycin-Dependent Enterococcus faecium in a Bone Marrow Transplant UnitClinical Infectious Diseases, 1999
- Streptococcus viridans bacteremia following autologous peripheral blood stem cell transplantationBone Marrow Transplantation, 1998
- Early gram-positive bacteremia in BMT recipients: impact of three different approaches to antimicrobial prophylaxisBone Marrow Transplantation, 1998
- Viridans Streptococcal Bacteremia and Viridans Streptococcal Shock Syndrome in Neutropenic Patients: Comparison Between Children and Adults Receiving Chemotherapy or Undergoing Bone Marrow TransplantationClinical Infectious Diseases, 1995
- Prevention of Gram-Positive Infections in Patients Treated with High-Dose Chemotherapy and Bone Marrow Transplantation: A Randomized Controlled Trial of VancomycinPediatric Hematology and Oncology, 1995
- Viridans streptococcal shock in bone marrow transplantation patientsAmerican Journal of Hematology, 1993
- Vancomycin, Ticarcillin, and Amikacin Compared with Ticarcillin-Clavulanate and Amikacin in the Empirical Treatment of Febrile, Neutropenic Children with CancerNew England Journal of Medicine, 1988
- MUCOSITIS AND α-STREPTOCOCCAL SEPSIS IN BONE MARROW TRANSPLANT RECIPIENTSThe Lancet, 1984
- DECREASED INCIDENCE OF VIRIDANS STREPTOCOCCAL SEPTICAEMIA IN ALLOGENEIC BONE MARROW TRANSPLANT RECIPIENTS AFTER THE INTRODUCTION OF ACYCLOVIRThe Lancet, 1984